Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.

[BACKGROUND] The C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index is a novel immune nutrition scoring system associated with cancer prognosis. This study investigated the association between the CALLY index and the long-term outcomes of patients with gastric cancer.

[METHODS] We included 175 patients with gastric cancer who underwent curative gastrectomies at the Department of Surgery, International University of Health and Welfare Hospital between January 2011 and October 2019. The CALLY index was calculated based on the levels of serum albumin, serum CRP, and peripheral lymphocyte count. Utilizing both univariate and multivariate analyses, the prognostic value of the CALLY index was investigated.

[RESULTS] In the multivariate analyses, disease stage (hazard ratio [HR], 7.85; 95% confidence interval [CI], 3.31-18.6; < .01), microvascular invasion (HR, 2.88; 95% CI, 1.30-6.36; < .01), and low CALLY index (HR, 2.18; 95% CI, 1.00-4.76; = .05) were independent and significant predictors of disease-free survival. Low body mass index (HR, 4.15; 95% CI, 1.63-10.6; < .01), advanced disease stage (HR, 8.22; 95% CI, 3.47-19.5; < .01), and low CALLY index (HR, 3.00; 95% CI, 1.3-6.93; = .01) were independent and significant predictors of overall survival. The low CALLY index group had a lower body mass index ( < .01), advanced disease stage ( < .01), and a higher Glasgow prognostic score ( < .01).

[CONCLUSIONS] The CALLY index may be associated with a poor prognosis for gastric cancer, highlighting the utility of a comprehensive assessment using inflammatory, nutritional, and immunological statuses.